1. Home
  2. VXRT vs TSE Comparison

VXRT vs TSE Comparison

Compare VXRT & TSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VXRT
  • TSE
  • Stock Information
  • Founded
  • VXRT N/A
  • TSE 2010
  • Country
  • VXRT United States
  • TSE United States
  • Employees
  • VXRT N/A
  • TSE N/A
  • Industry
  • VXRT Biotechnology: Biological Products (No Diagnostic Substances)
  • TSE Major Chemicals
  • Sector
  • VXRT Health Care
  • TSE Industrials
  • Exchange
  • VXRT Nasdaq
  • TSE Nasdaq
  • Market Cap
  • VXRT 119.0M
  • TSE 107.7M
  • IPO Year
  • VXRT N/A
  • TSE 2014
  • Fundamental
  • Price
  • VXRT $0.58
  • TSE $3.73
  • Analyst Decision
  • VXRT Strong Buy
  • TSE
  • Analyst Count
  • VXRT 2
  • TSE 0
  • Target Price
  • VXRT $3.00
  • TSE N/A
  • AVG Volume (30 Days)
  • VXRT 9.2M
  • TSE 286.9K
  • Earning Date
  • VXRT 08-07-2025
  • TSE 08-05-2025
  • Dividend Yield
  • VXRT N/A
  • TSE 1.07%
  • EPS Growth
  • VXRT N/A
  • TSE N/A
  • EPS
  • VXRT N/A
  • TSE N/A
  • Revenue
  • VXRT $47,395,000.00
  • TSE $3,394,000,000.00
  • Revenue This Year
  • VXRT N/A
  • TSE $1.84
  • Revenue Next Year
  • VXRT N/A
  • TSE $4.44
  • P/E Ratio
  • VXRT N/A
  • TSE N/A
  • Revenue Growth
  • VXRT 433.43
  • TSE N/A
  • 52 Week Low
  • VXRT $0.29
  • TSE $1.94
  • 52 Week High
  • VXRT $1.07
  • TSE $7.05
  • Technical
  • Relative Strength Index (RSI)
  • VXRT 59.05
  • TSE 66.90
  • Support Level
  • VXRT $0.48
  • TSE $2.92
  • Resistance Level
  • VXRT $0.78
  • TSE $3.85
  • Average True Range (ATR)
  • VXRT 0.08
  • TSE 0.22
  • MACD
  • VXRT 0.02
  • TSE 0.10
  • Stochastic Oscillator
  • VXRT 50.00
  • TSE 87.10

About VXRT Vaxart Inc

Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.

About TSE Trinseo PLC

Trinseo PLC is a materials company and manufacturer of latex and plastics products. The company's operating segments include Latex Binders, Americas Styrenics, Engineered Materials, and Polymer Solutions. Maximum revenue is generated from its Polymer Solutions segment, which consists of various polymers, the majority of which are for automotive, building, and construction applications. The product offerings of this segment include ABS, styrene-acrylonitrile, polystyrene, and polycarbonate products, which are marketed through brands like Magnum and Styron. Geographically, the company generates maximum revenue from Europe, followed by the United States, Asia-Pacific, and the Rest of the world.

Share on Social Networks: